Showing 118 of 118on this page. Filters & sort apply to loaded results; URL updates for sharing.118 of 118 on this page
Veracyte Announces Multiple Afirma GRID Presentations at ENDO 2024 ...
Veracyte Announces New Data Showing Potential of Afirma Genomic Test to ...
Veracyte Completes Acquisition of C2i Genomics | Veracyte, Inc ...
Veracyte Announces That Data From Multiple Studies Demonstrate “Real ...
Veracyte to buy C2i Genomics for up to $95M, includes $70M upfront
Veracyte to collaborate with Loxo Oncology on RNA sequencing-based ...
Veracyte Presents 15 Studies on Decipher Cancer Tests at ASCO GU ...
Veracyte Diagnostics Platform | Novel Approach to Cancer Testing
Pulmonary & Sleep of Tampa Bay | How the Veracyte Nasal Swab Works for ...
Veracyte Announces Seven Posters Highlighting Clinical Value of ...
Veracyte Resource Center – Molecular Diagnostics | Veracyte
Veracyte Diagnostic Labs - World-Class Science
Veracyte gene test may help curb thyroid surgeries
Veracyte BCG Matrix Analysis – MatrixBCG.com
Veracyte Announces that New Data Show Use of the Prosigna Test ...
The tumor microenvironment – J Klopper, MD – Afirma | Veracyte
Frequently Asked Questions - FAQs | Veracyte
Veracyte (VCYT) Introduces AI-Powered Cancer Detection - Faster and ...
The Future is Bright for Veracyte and Molecular Diagnostics | CMC Aureon
VERACYTE ANNOUNCES NEW CLINICAL VALIDATION DATA FOR RNA SEQUENCING ...
The Veracyte Afirma Test: Molecular Diagnostics | ARK
Veracyte to Develop Molecular Tests on Illumina's NextSeq 550Dx NGS ...
Veracyte - Genomax
PESTLE Analysis of Veracyte – MatrixBCG.com
Fair access to molecular testing – Decipher Prostate | Veracyte
Cancer Genomic Testing & Molecular Diagnostics | Veracyte Inc.
Veracyte Completes Acquisition of C2i Genomics
How Does Veracyte Company Work? – MatrixBCG.com
Veracyte Announces Release of Inaugural ESG Report - Biomarker News
Afirma GSC Test - Healthcare Providers | Veracyte
Afirma at AACE 2024 - Whole-Transcriptome Derived Analysis | Veracyte
Decipher Prostate Test - Providers | Veracyte
Veracyte Completes 2,400-Patient Trial for Lung Cancer Test | VCYT ...
Medical Science Liaison (Dallas/... | Veracyte | Levels.fyi
Veracyte Decipher Prostate Test Recommended in NCCN Guidelines
Veracyte - Los Angeles Times
Veracyte data presented at ATA annual meeting provide new insights into ...
Veracyte Acquires C2i Genomics | citybiz
Veracyte Stock: It's Sprinted 55% But Remains An Outlier | Investor's ...
Veracyte Releases Percepta® Genomic Sequencing Classifier For Lung ...
Veracyte Pops 12% on Collaboration With Bayer For Precision Oncology ...
Veracyte Announces Multiple Decipher Urologic Testing Abstracts to be ...
Assessing the data in patient reports – Afirma GSC | Veracyte
Afirma at AACE & ITC 2025 - Indeterminate Thyroid Nodules | Veracyte
Comparing Advanced Biomedical Technologies (OTCMKTS:ABMT) and Veracyte ...
Real-World Utility with Afirma GSC Benign Results | Veracyte
Veracyte Afirma Thyroid FNA Analysis | MLabs
Portal Terms of Use - Provider Ordering | Veracyte
Veracyte to Acquire Decipher Biosciences – enlightenbio Blog
In this photo illustration, the Veracyte logo is displayed on a ...
Veracyte completes NIGHTINGALE clinical utility trial enrollment for ...
Decipher Prostate Cancer Test - Patients | Veracyte
Specimen Processor @ Veracyte | Simplify Jobs
Veracyte Acquires C2i Genomics for $70M, Expanding into Minimal ...
Helping patients understand their risk of recurrence scores | Veracyte ...
Veracyte Announces Further European Reimbursement Expansion For ...
PESTEL Analysis of Veracyte – SWOTTemplate.com
Marketing Mix Analysis of Veracyte – MatrixBCG.com
Veracyte Announces Strategic Collaboration with Johnson & Johnson ...
Veracyte Announces In Vitro Diagnostic Agreement with Illumina to ...
Veracyte to Expand Patient Access to the Afirma® Gene Expression ...
Veracyte Logo - PNG Logo Vector Brand Downloads (SVG, EPS)
Veracyte to Release Third Quarter 2023 Financial Results on November 7 ...
Veracyte to Acquire C2i Genomics for $95 Million - News Center
Veracyte, Inc. on LinkedIn: Veracyte Announces New Data Suggesting ...
Veracyte appoints Phillip G. Febbo for two designations » World ...
Veracyte’s Decipher Prostate Test Predicts Progression
June 2016 Product Spotlight: Molecular Diagnostics | Clinical Lab Products
Three Abstracts Focusing on the Clinical Utility of Veracyte’s Genomic ...
Veracyte's Bladder Cancer Test Shows Breakthrough Accuracy in New ...
New Data Presented at CHEST 2023 Demonstrate the Clinical Utility of ...
Veracyte: The Transformation in Molecular Diagnostics
Deciphering the Future of Prostate Cancer Care: Veracyte’s Metastatic ...
Veracyte's Breakthrough: Revolutionizing Bladder Cancer Detection
New Data Suggest Veracyte’s Afirma Molecular Testing Capabilities Can ...
Veracyte's molecular tests decipher best treatment for urologic cancers
New data demonstrate accuracy of Veracyte’s whole-genome sequencing ...
Afirma Genomic Test | 2024 American Association of Clinical ...
Veracyte’s Decipher Prostate Test Is Now the Only Gene Expression Test ...
New Study Shows Veracyte’s Decipher Prostate Test is Prognostic for ...
Slide 4
PPT - Thyroid Nodules and Cancer PowerPoint Presentation, free download ...
#decipher #prostatecancer #biotechindustry #biotechnology #biotech # ...
Veracyte’s Decipher Prostate Test: A Breakthrough in Targeted Cancer Care
Real-World Data Presented at SUO 2023 Show that Veracyte’s Decipher ...
Assessment of BRAF Fusions in 177,227 Thyroid Nodules by Exome-Enriched ...
Pharma Fridays - June 7, 2024 - Endocrine News
Fighting breast cancer with genomic testing – Prosigna Breast Risk of ...
Veracyte's PAM50 Biomarker Shows 72% Success in Prostate Cancer Study ...
2024 ACRO Summit Sponsors
Veracyte, Inc. on LinkedIn: Afirma® Genomic Test for Thyroid Nodules
Veracyte’s Decipher Prostate Test: A Precision Medicine Game-Changer in ...
Veracyte: Investing In The Future Of Genomic Diagnostics (VCYT ...
This retrospective cohort study leveraged a novel national linkage of ...
Veracyte's test predicts prostate cancer patients | Business News Today ...
New Data Presented at ESMO 2022 Show Veracyte’s Decipher Prostate ...
A Validated Nasal Swab Classifier Developed Using Machine Learning and ...
Slide 10
Molecular Diagnostics - Part 2: Tackling the How
Clinical Validation Data Published in CHEST Demonstrate that Veracyte’s ...
Diagnostic Tests Maker Veracyte's Q2 Is 'All-Around Very Good Quarter ...
#genomic | Veracyte, Inc.
_LOGO_for_press_releases.jpg){kind=logo}
